Press Releases

TB Alliance Adds New Member to Research & Development Team The Global Alliance for TB Drug Development (TB Alliance), a

TB Alliance Bolsters Research & Development Team The TB Alliance has announced the appointment of Dr. Ann Ginsberg as Head

WHAT: Release of startling findings from the latest World Health Organization report on multi-drug-resistant strains in tuberculosis (MDR-TB): A total

Veteran of Academia and Industry brings 20-plus years of expertise to International Public-Private Partnership The TB Alliance has announced the

The TB Alliance reached another important milestone in the portfolio building process on April 22. We announced the launch of

New Tuberculosis Drugs Required o Eliminate Epidemic, Meet Economic Development Goals Health Experts Urge Public & Industry Commitments New York,

This year’s World TB Day was held on March 24, 2002 and carried the theme, “Stop TB, Fight Poverty.” This

Groundbreaking Agreement for New Tuberculosis Treatment EMERYVILLE, CA and NEW YORK. Chiron Corporation (Nasdaq: CHIR) and the Global Alliance for

The TB Alliance released its newest publication, Economics of TB Drug Development, which is the first analysis of the TB

Dr. Maria C. Freire, Ph.D. has been named the new chief executive officer of the Global Alliance for TB Drug